Reply : Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction : Who Benefits ?

Publié dans Journal of the American College of Cardiology 2016 Nov 15;68(20):2241-2242 Auteurs : Beygui F, Montalescot G, ALBATROSS Investigators. Article disponible en consultant le site Letter The letter by Drs. Weir and Petrie points to the hypothetic benefit of mineralocorticoid receptor blockade (MRA) in preventing left ventricular remodeling and reducing mortality in patients with…

Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC) : an open-label, blinded-endpoint, randomised controlled superiority trial

Publié dans Lancet 2016 Oct 22;388(10055):2015-2022 Auteurs : Cayla G, Cuisset T, Silvain J, Leclercq F, Manzo-Silberman S, Saint-Etienne C, Delarche N, Bellemain-Appaix A, Range G, El Mahmoud R, Carrié D, Belle L, Souteyrand G, Aubry P, Sabouret P, du Fretay XH, Beygui F, Bonnet JL, Lattuca B, Pouillot C, Varenne O, Boueri Z, Van…

Exome Sequencing of Extreme Clopidogrel Response Phenotypes

Publié dans American Society for Clinical Pharmacology and Therapeutics 2016 Sep;100(3):287-94 Auteurs : Scott SA, Collet JP, Baber U, Yang Y, Peter I, Linderman M, Sload J, Qiao W, Kini AS, Sharma SK, Desnick RJ, Fuster V, Hajjar RJ, Montalescot G, Hulot JS. Article disponible en consultant le site Abstract Interindividual variability in platelet aggregation…

Cangrelor : Fixing Life or Just a Leak ?

Publié dans Journal of the American College of Cardiology : Cardiovascular Interventions 2016 Sep 26;9(18):1914-6 Auteurs : Kerneis M, Silvain J, Montalescot G; ACTION Study Group. Article disponible en consultant le site Abstract Editorial comment : There is a strong argument in favor of cangrelor to better control the troponin leak following PCI but no…